OTC - ACTIVE INGREDIENT SECTION
Active Ingredients:
Zinc Oxide: 18.6%
Titanium Dioxide: 2.0%
Youth Protection SPF 30
- Manufacturer
- Allure Labs, Inc
- Effective date
- 2020-12-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:00:30
Label at a glance#
ProductYouth Protection SPF 30
Active ingredientZINC OXIDE, TITANIUM DIOXIDE
Label structure11 sections
Label contents#
Full prescribing information#
OTC - PURPOSE SECTION
Purpose:Sunscreen
INDICATIONS & USAGE SECTION
Uses:
- Helps prevent sunburn.
- If used as directed with other sun protection meausres, this product decreases the risk of skin cancer and early skin aging aging caused by the sun.
WARNINGS SECTION
Warings:
- For External Use Only
- Do not use on damged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
- Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If product is swallowed, get medical helps or contact a Poison Control Center right away
INDICATIONS & USAGE SECTION
Directions:
- Apply liberally 15 minutes before sun exposure.
- Children under 6 month of age: Ask a doctor.
- Reapply at least every 2 hours.
OTHER SAFETY INFORMATION
Other information:
- Protect the product in this container from excessive heat and direct sun.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Water (Aqua), Cyclopentasiloxane, Glycerin, Butyrospermum Parkii Nut Extract, Dimethicone, Polyglyceryl-3 Polydimethylsiloxyethyl Dimethicone, Jojoba Esters , Glyceryl Stearate, PEG-100 Stearate, Sorbitan Stearate, PEG-100, Tetrahexyldecyl Ascorbate, Cyclohexasiloxane, Galactoarabinan, Cetyl Alcohol, Bis(Cyano Butylacetate) Anthracenediylidene, Glyceryl Acrylate/Acrylic Acid Copolymer , Triethoxysilylethyl Polydimethylsiloxyethyl Hexyl Dimethicone, Phenoxyethanol, Caprylyl Glycol, Ethylhexylglycerin, Hexylene Glycol, Adipic Acid/Neopentyl Glycol Crosspolymer, VP/VA Copolymer, Hydroxypropyl Methylcellulose, Amodimethicone, Steareth-20, Caprylic/Capric Triglyceride, Teprenone, Acetyl Hexapeptide-30, Arginine, Sodium Hyaluronate , Hydrolyzed Glycosaminoglycans , Propylene Glycol, Polygonum Aviculare Extract, Cetearyl Olivate, Sorbitan Olivate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Squalane, Polysorbate 60, Xanthan Gum, Camellia Sinensis Leaf Extract, Acetyl Hexapeptide-8, Gardenia Jasminoides Meristem Cell Culture, Sclerotium Gum, C12-15 Alkyl Benzoate, Tribehenin, Ceramide NG, PEG-10 Phytosterol, Palmitoyl Hexapeptide-12, Tocopheryl Acetate, Tocopherol, Lecithin , Arabidopsis Thaliana Extract , Micrococcus Lysate, Plankton Extract , Glucosamine HCl , Laminaria Digitata Extract, Saccharomyces Cerevisiae Extract, Caesalpinia Spinosa Fruit Pod Extract, Helianthus Annuus (Sunflower) Sprout Extract, Urea, PPG-12/SMDI Copolymer, Leontopodium Alpinum Meristem Cell Culture, Crithmum Maritimum Extract, Ergothioneine, Aluminum Hydroxide, Stearic Acid, Chlorphenesin, Sodium Benzoate, Potassium Sorbate
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Manufactured for DermaQuest®, Inc.
Hayward, CA 94544
1272 GK,NL Made in USA
dermaquestinc.com
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62742-4068-2 | 2020-12-22 | C162847 | 48780-1 | 9855e2a2-4251-60a7-e053-dbdaa90a05bd | DRUG FACTS |
| 62742-4068-3 | 2020-12-22 | C162847 | 48780-1 | 9855e2a2-4251-60a7-e053-dbdaa90a05bd | DRUG FACTS |
| 62742-4068-4 | 2020-12-22 | C162847 | 48780-1 | 9855e2a2-4251-60a7-e053-dbdaa90a05bd | DRUG FACTS |
| 62742-4068-2 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4251-60a7-e053-dbdaa90a05bd | DRUG FACTS |
| 62742-4068-3 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4251-60a7-e053-dbdaa90a05bd | DRUG FACTS |
| 62742-4068-4 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4251-60a7-e053-dbdaa90a05bd | DRUG FACTS |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| ZINC CATION | ACTIVE MOIETY | 13S1S8SF37 | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ACETYL HEXAPEPTIDE-8 | INACTIVE INGREDIENT | L4EL31FWIL | 1 | |
| ADIPIC ACID | INACTIVE INGREDIENT | 76A0JE0FKJ | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALUMINUM HYDROXIDE | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| ARABIDOPSIS THALIANA | INACTIVE INGREDIENT | AI3L60HQ81 | 1 | |
| BETASIZOFIRAN | INACTIVE INGREDIENT | 2X51AD1X3T | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CERAMIDE 2 | INACTIVE INGREDIENT | C04977SRJ5 | 1 | |
| CETEARYL OLIVATE | INACTIVE INGREDIENT | 58B69Q84JO | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| COPOVIDONE K25-31 | INACTIVE INGREDIENT | D9C330MD8B | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ERGOTHIONEINE | INACTIVE INGREDIENT | BDZ3DQM98W | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| GALACTOARABINAN | INACTIVE INGREDIENT | SL4SX1O487 | 1 | |
| GLUCOSAMINE HYDROCHLORIDE | INACTIVE INGREDIENT | 750W5330FY | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| GREEN TEA LEAF | INACTIVE INGREDIENT | W2ZU1RY8B0 | 1 | |
| HEXYLENE GLYCOL | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%) | INACTIVE INGREDIENT | 86FQE96TZ4 | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| JOJOBA BUTTER | INACTIVE INGREDIENT | XIA46H803R | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PEG-10 RAPESEED STEROL | INACTIVE INGREDIENT | 258O76T85M | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYETHYLENE GLYCOL 4500 | INACTIVE INGREDIENT | TVH7653921 | 1 | |
| POLYGONUM AVICULARE TOP | INACTIVE INGREDIENT | ZCD6009IUF | 1 | |
| POLYSORBATE 60 | INACTIVE INGREDIENT | CAL22UVI4M | 1 | |
| PPG-12/SMDI COPOLYMER | INACTIVE INGREDIENT | 1BK9DDD24E | 1 | |
| SHEANUT OIL | INACTIVE INGREDIENT | O88E196QRF | 1 | |
| SORBITAN MONOSTEARATE | INACTIVE INGREDIENT | NVZ4I0H58X | 1 | |
| SORBITAN OLIVATE | INACTIVE INGREDIENT | MDL271E3GR | 1 | |
| SQUALANE | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| STEARETH-20 | INACTIVE INGREDIENT | L0Q8IK9E08 | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| TEPRENONE | INACTIVE INGREDIENT | S8S8451A4O | 1 | |
| TETRAHEXYLDECYL ASCORBATE | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| UREA | INACTIVE INGREDIENT | 8W8T17847W | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 | |
| YEAST | INACTIVE INGREDIENT | 3NY3SM6B8U | 1 |
Products#
Every source-derived product name is available through these pages.
- Youth Protection SPF 30
- Zinc Oxide and Titanium Dioxide
- CAESALPINIA SPINOSA FRUIT POD
- CRITHMUM MARITIMUM
- SODIUM BENZOATE
- POTASSIUM SORBATE
- WATER
- CYCLOMETHICONE 5
- GLYCERIN
- SHEANUT OIL
- JOJOBA BUTTER
- GLYCERYL MONOSTEARATE
- PEG-100 STEARATE
- SORBITAN MONOSTEARATE
- POLYETHYLENE GLYCOL 4500
- CYCLOMETHICONE 6
- GALACTOARABINAN
- TETRAHEXYLDECYL ASCORBATE
- PHENOXYETHANOL
- CAPRYLYL GLYCOL
- ETHYLHEXYLGLYCERIN
- HEXYLENE GLYCOL
- ADIPIC ACID
- COPOVIDONE K25-31
- HYPROMELLOSES
- STEARETH-20
- MEDIUM-CHAIN TRIGLYCERIDES
- TEPRENONE
- HYALURONATE SODIUM
- POLYGONUM AVICULARE TOP
- CETEARYL OLIVATE
- SORBITAN OLIVATE
- HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (45000 MPA.S AT 1%)
- SQUALANE
- POLYSORBATE 60
- XANTHAN GUM
- CETYL ALCOHOL
- GREEN TEA LEAF
- ACETYL HEXAPEPTIDE-8
- BETASIZOFIRAN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62742-4068 | 62742-4068-1, 62742-4068-2, 62742-4068-3, 62742-4068-4 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | CREAM / TOPICAL | 3300 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYSTEM / TOPICAL | 54 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | OINTMENT / TOPICAL | 20 %w/w | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | TABLET, COATED / ORAL | NA | ||
| COPOVIDONE K25-31 | COPOVIDONE K25-31 | D9C330MD8B | SUSPENSION / ORAL | 172 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | OINTMENT / TOPICAL | NA | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / ORAL | 62.5 mg/5ml | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 59 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET, COATED / ORAL | 0.25 mg | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | TABLET / ORAL | 4 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| STEARETH-20 | STEARETH-20 | L0Q8IK9E08 | CREAM / TOPICAL | 4.15 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | GUM, CHEWING / BUCCAL | 5 mg | ||
| UREA | UREA | 8W8T17847W | TABLET, COATED / ORAL | 0.02 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / ORAL | 84 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| POLYSORBATE 60 | POLYSORBATE 60 | CAL22UVI4M | SUSPENSION / ORAL | 125 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | 105 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| POLYETHYLENE GLYCOL 4500 | POLYETHYLENE GLYCOL 4500 | TVH7653921 | CAPSULE / ORAL | 18 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | CREAM / TOPICAL | 177 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CAPSULE, EXTENDED RELEASE / ORAL | 32.4 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| UREA | UREA | 8W8T17847W | SYSTEM / TOPICAL | 840 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | SUSPENSION / TOPICAL | 2.15 %w/w | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 23 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION/ DROPS / OPHTHALMIC | 3 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 120 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | 250 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | ||
| SORBITAN MONOSTEARATE | SORBITAN MONOSTEARATE | NVZ4I0H58X | LOTION / TOPICAL | 89 mg | ||
| UREA | UREA | 8W8T17847W | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| ALUMINUM HYDROXIDE | ALUMINUM HYDROXIDE | 5QB0T2IUN0 | CREAM / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| SQUALANE | SQUALANE | GW89575KF9 | CREAM / TOPICAL | 6 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b615c468-f204-8b5c-e053-2a95a90a68c3 | d7c8e1b5-106c-4fac-8069-796cd27e629d | 2020-12-09 | Warnings | b615c468-f204-8b5c-e053-2a95a90a68c3 d7c8e1b5-106c-4fac-8069-796cd27e629d |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.